Home / Sweden / Hansa Biopharma AB
Hansa Biopharma AB Short position disclosed on September 24, 2026.
Follow
2.64% of the capital sold short
4 disclosing funds
434 disclosures on record
SE0002148817 ISIN code
Evolution of the disclosed total 0% 2% 4% 6%
Oct 2025 Jan 2026 Apr 2026 Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up. Over the whole history, the total peaked at 4.82% on March 10, 2025. The shaded band matches the twelve months of the first chart. January 15, 2019 today
Open positions In the United States HNSBF (OTC): 25,732 shares sold short on September 15, 2026. FINRA names no fund.
On the other side: the funds that hold Hansa Biopharma AB Titelia
Follow by RSS
Get the moves on Hansa Biopharma AB by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures 434 disclosures on record for this share. Date Fund % of capital End of publication July 12, 2021 Arrowstreet Capital Limited Partnership 0.69% July 9, 2021 Citadel Advisors LLC 0.81% July 7, 2021 Arrowstreet Capital Limited Partnership 0.70% July 2, 2021 Citadel Advisors LLC 0.70% June 28, 2021 Citadel Advisors LLC 0.62% June 24, 2021 PDT Partners LLC 0.00% June 22, 2021 PDT Partners LLC 0.52% June 18, 2021 Arrowstreet Capital Limited Partnership 0.61% June 16, 2021 Citadel Advisors LLC 0.53% June 11, 2021 Arrowstreet Capital Limited Partnership 0.58% June 9, 2021 PDT Partners LLC 0.00% June 2, 2021 PDT Partners LLC 0.51% May 17, 2021 Arrowstreet Capital Limited Partnership 0.60% May 10, 2021 Arrowstreet Capital Limited Partnership 0.50% January 26, 2021 Worldquant LLC 0.00% January 22, 2021 Worldquant LLC 0.58% January 22, 2021 POINT72 Asset Management LP 0.00% January 15, 2021 Worldquant LLC 0.63% January 14, 2021 Worldquant LLC 0.53% January 11, 2021 Point72 Asset Management LP 0.59% November 4, 2020 Voleon Capital Management LP 0.00% November 3, 2020 Voleon Capital Management LP 0.54% October 29, 2020 Systematica Investments Limited 0.00% October 27, 2020 Voleon Capital Management LP 0.69% October 26, 2020 Voleon Capital Management LP 0.70% October 22, 2020 Voleon Capital Management LP 0.63% October 19, 2020 Voleon Capital Management LP 0.50% October 6, 2020 Voleon Capital Management LP 0.00% October 1, 2020 Voleon Capital Management LP 0.57% September 25, 2020 Voleon Capital Management LP 0.66% September 21, 2020 Systematica Investments Limited 0.50% September 9, 2020 Voleon Capital Management LP 0.71% August 25, 2020 Voleon Capital Management LP 0.60% August 20, 2020 Voleon Capital Management LP 0.59% August 7, 2020 Voleon Capital Management LP 0.69% August 3, 2020 Voleon Capital Management LP 0.79% July 30, 2020 Voleon Capital Management LP 0.92% July 28, 2020 Voleon Capital Management LP 1.09% July 24, 2020 Voleon Capital Management LP 1.26% July 23, 2020 Voleon Capital Management LP 1.39% July 22, 2020 Voleon Capital Management LP 1.44% July 20, 2020 Voleon Capital Management LP 1.58% July 17, 2020 Voleon Capital Management LP 1.60% July 16, 2020 Voleon Capital Management LP 1.57% July 14, 2020 Voleon Capital Management LP 1.64% July 10, 2020 Voleon Capital Management LP 1.71% July 6, 2020 Voleon Capital Management LP 1.61% July 1, 2020 Voleon Capital Management LP 1.51% June 30, 2020 Systematica Investments Limited 0.00% June 25, 2020 Voleon Capital Management LP 1.40%
Download 434 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Page 6 of 9
Other companies sold short in Sweden Cite this page The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Hansa Biopharma AB, source Finansinspektionen, data as at September 24, 2026, https://www.quivad.com/action/hansa-biopharma-ab?page=6